Consumer Retailing Healthcare Sector

Nano-X Imaging

Market Cap: US$327.4m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Cytek Biosciences

Market Cap: US$325.5m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Varex Imaging

Market Cap: US$325.0m

Designs, manufactures, and sells X-ray imaging components.

Alpha Teknova

Market Cap: US$319.0m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Tvardi Therapeutics

Market Cap: US$312.6m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

Cidara Therapeutics

Market Cap: US$311.3m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

National Research

Market Cap: US$310.8m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Erasca

Market Cap: US$306.0m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

EBR Systems

Market Cap: AU$474.2m

Develops implantable systems for wireless tissue stimulation.

Cryoport

Market Cap: US$302.3m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Aurora Cannabis

Market Cap: CA$415.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

American Oncology Network

Market Cap: US$298.9m

Through its subsidiaries, provides oncology management services in the United States.

XOMA Royalty

Market Cap: US$297.4m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Abeona Therapeutics

Market Cap: US$297.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Cresco Labs

Market Cap: CA$408.7m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

NervGen Pharma

Market Cap: CA$404.2m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Compass Therapeutics

Market Cap: US$291.8m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Imricor Medical Systems

Market Cap: AU$449.3m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Heron Therapeutics

Market Cap: US$288.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Phathom Pharmaceuticals

Market Cap: US$287.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Ocugen

Market Cap: US$279.7m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Immutep

Market Cap: AU$430.8m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Sanara MedTech

Market Cap: US$273.6m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Pacific Biosciences of California

Market Cap: US$273.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Candel Therapeutics

Market Cap: US$272.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Corvus Pharmaceuticals

Market Cap: US$269.1m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Canopy Growth

Market Cap: CA$371.7m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Oncology Institute

Market Cap: US$268.6m

An oncology company, provides various medical oncology services in the United States.

Entrada Therapeutics

Market Cap: US$264.4m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Oceania Healthcare

Market Cap: NZ$441.8m

Owns and operates retirement villages and care centres in New Zealand.

Health Catalyst

Market Cap: US$263.1m

Provides data and analytics technology and services to healthcare organizations in the United States.

Terns Pharmaceuticals

Market Cap: US$262.9m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Neuronetics

Market Cap: US$262.6m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Viemed Healthcare

Market Cap: US$260.9m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Alpha Tau Medical

Market Cap: US$260.0m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Lifecore Biomedical

Market Cap: US$259.2m

Operates as an integrated contract development and manufacturing organization in the United States.